Controversial American scientist Yoshihiro Kawaoka criticised over safety levels of research into pandemic H1N1 flu virus
He created a virus that could render the human immune system defenceless
Steve Connor is the Science Editor of The Independent. He has won many awards for his journalism, including five-times winner of the prestigious British science writers’ award; the David Perlman Award of the American Geophysical Union; twice commended as specialist journalist of the year in the UK Press Awards; UK health journalist of the year and a special merit award of the European School of Oncology for his investigative journalism. He has a degree in zoology from the University of Oxford and has a special interest in genetics and medical science, human evolution and origins, climate change and the environment.
Wednesday 02 July 2014
Senior scientists have criticised an American university for allowing controversial research on enhancing a pandemic strain of flu virus to be undertaken in a laboratory with a relatively low level of biosecurity.
The University of Wisconsin-Madison was labelled irresponsible and negligent for allowing one of its scientists, Professor Yoshihiro Kawaoka, to genetically manipulate pandemic H1N1 flu virus in a laboratory categorised as biosafety level-2 (BSL-2).
Other experts believe that the research, which involved the creation of a strain of pandemic flu that has “escaped” from the control of the human immune system, should have been done at least at BSL-3 or even BSL-4, the most secure level of biosafety reserved for the most dangerous pathogens.
When pandemic H1N1 emerged in 2009 it killed between 151,000 and 540,000 people in the first year of the outbreak. Since then, most people have acquired a level of antibody immunity to the virus, which is now classified as “seasonal flu”.
The Independent revealed yesterday that Professor Kawaoka has for the past four years been working on ways of mutating the 2009 pandemic strain of H1N1 flu so that it is no longer neutralised by the antibodies that provide immunity for the wider population.
READ MORE: Exclusive: Controversial US scientist creates deadly new flu strain for pandemic research
Rebecca Moritz, who is responsible for overseeing the work on “select agents” at Wisconsin said that it is normal for such work on flu viruses to be done at BSL-2, which covers work on viruses and bacteria that cause only mild disease in humans or are difficult to pass on through airborne transmission.
“The 2009 pandemic strain of influenza is studied in many laboratories across the world. It is easily isolated from anyone who gets sick with influenza virus during the flu season. The appropriate biosafety level for this virus is BSL-2,” Ms Moritz said.
However, leading experts in infectious diseases were amazed to discover that this work was carried out in a BSL-2 laboratory with only relatively minor precautions against accidental releases compared to the two highest levels of biosafety.
“That would be incredible if true because a modified virus that evades available protective immunity clearly mandates much greater biosafety,” said Professor David Relman of Stanford University in California, a member of the US’s National Science Advisory Board for Biosecurity.
“If real, this work is irresponsible, and unduly places humanity at risk of death and illness. The apparent lack of common sense and insensitivity to our responsibility as scientists to do no harm, is striking. It would seem that this area of research is now an unregulated free for all,” Professor Relman said.
Professor Richard Ebright, a molecular biologist at Rutgers University in New Jersey, said that the research threatens to undermine efforts to control influenza rather than to help to curb future flu pandemics.
“If the reports are correct, Kawaoka, single-handedly, has rendered useless the billions of dollars and millions of person-hours expended in mass vaccination against the 2009 pandemic influenza virus and, single-handedly, has placed millions of lives at risk,” Professor Ebright said.
“Incredibly, the ‘research’ is reported to have been performed at biosafety level 2, the same biosafety level as a physician's or dentists's office: no required biosafety protections beyond an open cabinet, gown, and gloves,” he said.
The H1N1 flu virus from 2009
Professor Sir Andrew McMichael, a vaccine expert at Oxford University, said that there are mounting concerns about this kind of work and there needs to be a wider debate between flu scientists, funding bodies and biosafety experts.
“It’s very disturbing and poses real risks that do not seem to be appreciated fully by those involved. Is it really being done at BSL-2? That seems unbelievable,” Sir Michael said.
However, Professor Wendy Barclay, a flu researcher at Imperial College said there was nothing wrong with Professor Kawaoka carrying out his research in a BSL-2 lab. “In nature there is no containment. He’s only doing what happens in nature every day,” Professor Barclay said.
Professor Simon Wain-Hobson, a virologist at the Pasteur Institute in Paris, said that the work has a dual function because it is about enhancing the genetic make-up of a human infectious agent, and the research should therefore only be done, if it is done at all, at the highest biosafety levels.
“If it escaped it would be equivalent to a new pandemic virus. It seems there was a tremendous lack of oversight in the funding and execution of this research at Wisconsin,” Professor Wain-Hobson said.
Video: Chief Medical Officer for England calls for new antibiotics
The four categories of biosafety level for laboratories
Biosafety level-1 (BSL-1)
For work on bacteria and viruses that do not generally cause disease in healthy adults. Precautions, such as washing hands with anti-bacterial soaps, are minimal and the work can be done on an open bench-top.
Biosafety level-2 (BSL-2)
For infectious agents with a moderate hazard to health or the environment, such as viruses or bacteria that cause mild disease in humans or are difficult to contract by airborne transmission. Gloves and gowns.
Biosafety level-3 (BSL-3)
This is for agents that can cause severe or fatal diseases in humans, such as plague, yellow fever and West Nile virus. Requires protective clothing and fume cupboards where the work is carried out.
Biosafety level-4 (BSL-4)
The highest level of safety for the most dangerous pathogens, such as Ebola, Marburg and Lassa viruses. Measures include high-security buildings, multiple showers, positive-pressure personnel suits and air filters.
- 1 Isis burns thousands of books and rare manuscripts from Mosul's libraries
- 2 Scarlett Johansson new band 'already hit with legal complaint' from another The Singles
- 3 Husband and wife die holding hands within hours of each other after 67 years of marriage
- 4 The remarkable archaeological underwater discovery that could open up a new chapter in the study of European and British prehistory
- 5 'Jihadi John': CAGE representative storms off Sky News accusing Kay Burley of Islamophobia
Isis burns thousands of books and rare manuscripts from Mosul's libraries
Husband and wife die holding hands within hours of each other after 67 years of marriage
Mohammed Emwazi: Nine things we know about Isis militant 'Jihadi John'
'Jihadi John': CAGE representative storms off Sky News accusing Kay Burley of Islamophobia
'Jihadi John': Mohammed Emwazi – from British computer programmer to Isis executioner
Oscars 2015: Birdman beats Boyhood as Eddie Redmayne and Patricia Arquette win big - as it happened
New theory could prove how life began and disprove God
Half of Ukip voters say they are prejudiced against people of other races
'Cash for access' scandal: Sir Malcolm Rifkind says 'unrealistic' for MPs to live on £67,000 salary
Aqsa Mahmood branded a 'disgrace' by her parents after claims she recruited three UK girls flying to Middle East
This is what it's like to be dead, according to a guy who died for a bit
£21000 - £23000 per annum: Recruitment Genius: This software development compa...
Negotiable: Recruitment Genius: Do you wish to be part of an exciting journey ...
£25,000: Anna Woodward: My client is a rapidly expanding global company who sp...
£30,000: Beverley James: A fantastic opportunity has arisen for a person looki...